JAN
Janus Living, Inc.
stockNYSE
janone inc. develops treatments for conditions that cause severe pain. the company, through its non-addictive pain-relieving drugs, focuses on reduction for need of opioid prescriptions to treat disease associated pain that can lead to opioid abuse. its lead candidate jan101 provides slow-release formulation of sodium nitrite therapeutic for treatment of peripheral artery disease (pad). the company was formerly known as appliance recycling centers of america, inc. and changed its name to janone inc. in september 2019. janone inc. was founded in 1976 and is headquartered in las vegas, nevada.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 30.04 | 2026-09-28 | -3.16% | 1.662 |
| 1M | 30.79 | 2026-09-04 | -5.52% | -0.126 |
| 3M | 29.38 | 2026-07-06 | -0.99% | -0.263 |
| 6M | 23.35 | 2026-04-06 | +24.58% | -0.013 |
| 1Y | 23.60 | 2026-03-20 | +23.26% | 0.129 |
| 2Y | 2.23 | 2024-07-12 | +1204.48% | — |
| 5Y | 6.22 | 2021-10-04 | +367.69% | -2.195 |
Janus Living, Inc. (NYSE:JAN) stock price today is $29.09, and today's volume is 1,804,543. JAN is up 1.218% today. The 30 day average volume is 1.74M. JAN market cap is $6.82B with 234.37M shares outstanding.